Autopsy report · NCT00670956

Prenatal Steroids for Treatment of Congenital Cystic Adenomatoid Malformations (CCAM)

Cause of deathSlow enrollment Automatic label, confidence 0.9, unverified. How labels are made.

“Recruitment has been poor. Study drug is being offered as part of standard care of women carrying a pregnancy diagnosed with CCAM”

The sponsor’s own words in the registry.

Life of this trial

Ran for about 3 years 5 months before it stopped.
1 participant enrolled.
Results were posted on the registry 3 years 6 months after it ended.

Vital statistics

Status: Terminated
Phase: Phase 1, Phase 2
Sponsor: University of California, San Francisco
Sponsor type: University, hospital or other
Conditions: Congenital Cystic Adenomatoid Malformation
Interventions: Betamethasone; Placebo
Participants: 1
Sites: 3
Countries: United States

Look deeper

The official registry record (the source of truth)
Record history: every change the sponsor made
Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.